Two of LMC’s Andrologists, Mr Alnajjar and Prof Muneer, along with other experts in the field, have recently published a study looking at current international guidelines on Peyronie’s Disease. 

 

Objective

To compare major Peyronie’s disease (PD) guidelines, highlight key similarities and differences among panel recommendations, and identify areas requiring further research.

 

Methods

An extensive review was conducted to analyse and compare diagnostic and treatment recommendations from publicly available guidelines published by the American Urological Association, European Association of Urology, CanadianUrological Association, and the International Society of Sexual Medicine. Key similarities and differences regarding PD definition, evaluation, non-surgical treatments, and surgical management were systematically compared.

 

Results

Areas of general consensus across guidelines include the importance of comprehensive history-taking for PD diagnosis and the role of intracavernosal injection as the ‘gold standard’ for assessing penile deformity prior to invasive intervention. Shared decision-making and thorough patient counselling are universally emphasised. Plication or incision and grafting surgery is generally reserved for patients with preserved erectile function, whereas penile prosthesis implantation is the preferred surgical option for those with erectile dysfunction unresponsive to medical therapy. Non-surgical treatments remain an area of controversy due to limited evidence of efficacy; however, intralesional injections are recognised by all panels as a potential treatment option, especially in the acute phase. Further research intoPD pathophysiology and rigorous outcomes studies are needed to inform novel treatments and refine surgical management strategies.

 

Conclusion

While major urological societies demonstrate substantial consensus on several aspects of PD evaluation and management,key areas of divergence remain, underscoring the need for further research to guide evidence-based care.

 

Citation:

Chierigo, F., Fallara, G., Tozzi, M., Salonia, A., Ferro, M., Alnajjar, H.M., Muneer, A. and Pang, K.H. (2026), Guideline of guidelines: Peyronie’s disease. BJU Int. https://doi.org/10.1111/bju.70201

 

What is Peyronie’s Disease? 

Peyronie’s Disease is caused by fibrous scar tissue (or plaque) that develops under the skin of the penis. Symptoms of Peyronie’s disease include:

  • Significant curvature
  • Pain
  • Erectile dysfunction in some cases 

 There are usually two phases to this condition. The first is the acute phase, presenting with pain and changing curvature. The second is the chronic phase where the plaque hardens, the curve stabilizes, and pain often subsides.

 Peyronie’s is treatable. It is important to seek early evaluation by a urologist or andrologist, as treatment is more effective when begun in the early stages.

 You can read more about Peyronie’s Disease on our blog here. Other articles regarding the disease and treatment options can be found here. 

 

If you’re concerned that you have symptoms that may be Peyronie’s Disease then please get in touch with one of our expert Andrologists. This disease is treatable if caught early, and here at London Men’s Clinic we short wait times offering non-invasive options as well as surgical treatments. Get in touch here.